Evidence map›Paper›PMID 31765439›Full record

ArticlePloS one2019

Effects of the solubility of yeast cell wall preparations on their potential prebiotic properties in dogs.

Stephanie de Souza Theodoro, Thaila Cristina Putarov, Caroline Tiemi, Lara Mantovani Volpe, Carlos Alberto Ferreira de Oliveira, Maria Beatriz de Abreu Glória, Aulus Cavalieri Carciofi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Potential benefits of yeastFrontiers in veterinary science · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Disclosing the Genomic Diversity among Members of theApplied and environmental microbiology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Stephanie de Souza TheodoroVeterinary Medicine and Surgery Department, College of Agrarian and Veterinarian Sciences (FCAV), São Paulo State University-UNESP, Jaboticabal, São Paulo, Brazil.ORCID 0000-0001-8075-458X
Thaila Cristina PutarovVeterinary Medicine and Surgery Department, College of Agrarian and Veterinarian Sciences (FCAV), São Paulo State University-UNESP, Jaboticabal, São Paulo, Brazil.
Caroline TiemiVeterinary Medicine and Surgery Department, College of Agrarian and Veterinarian Sciences (FCAV), São Paulo State University-UNESP, Jaboticabal, São Paulo, Brazil.
Lara Mantovani VolpeVeterinary Medicine and Surgery Department, College of Agrarian and Veterinarian Sciences (FCAV), São Paulo State University-UNESP, Jaboticabal, São Paulo, Brazil.
Carlos Alberto Ferreira de OliveiraBiorigin Brasil, Lençois Paulistas, São Paulo, Brazil.
Maria Beatriz de Abreu GlóriaPharmacy Faculty, Minas Gerais Federal University (UFMG), Belo Horizonte, Minas Gerais, Brazil.
Aulus Cavalieri CarciofiVeterinary Medicine and Surgery Department, College of Agrarian and Veterinarian Sciences (FCAV), São Paulo State University-UNESP, Jaboticabal, São Paulo, Brazil.ORCID 0000-0003-3859-3983
Universidade Estadual Paulista (Unesp) · BRUniversidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Derivatives of yeast cell wall (YCW) have been studied for their potential prebiotic effects. Recently, new purified and soluble preparations have been developed in an attempt to increase their biological actions. Two YCW preparations, one conventional and another with higher solubility of the mannan oligosaccharide fraction, were evaluated on dogs. One food formulation was used, divided into the following treatments: CON-control, without yeast cell wall addition; YCW-addition of 0.3% of a conventional yeas cell wall extract; YCWs-addition of 0.3% of a yeast cell wall extract with high mannan oligosaccharide solubility. Twenty-four beagle dogs were used, eight per food, distributed on a block design. Blocks lasted 32 days, and TNF-a, IL-6, IL-10, ex vivo production of hydrogen peroxide and nitric oxide by peripheral neutrophils and monocytes, phagocytic index, and fecal IgA were evaluated at the beginning and end of each period. Additionally, nutrient digestibility, feces production and quality, and fermentation products were quantified. The results were evaluated by analysis of variance and compared using the Tukey test (P<0.05), using the basal immunological parameters as a covariate. The inclusion of YCWs reduced fat digestibility (P<0.05), increased the concentration of butyrate and putrescine, and reduced lactate in feces (P<0.05), showing that mannan oligosaccharide solubilization resulted in higher fermentation of this compound and altered the metabolism of the gut microbiota. Lower IL-6 on serum was verified for dogs fed the YCWs diet (P<0.05), suggesting a reduction in the inflammatory activity of dogs. Higher phagocytic index was verified for peripheral monocytes after the intake of the YCW food, suggesting better innate immunity. In conclusion, the solubilization of the mannooligosaccharide fraction alters its interaction with gut microbiota and biological actions in animals, although both yeast cell wall preparations exhibited prebiotic effects on dogs.

Indexed as

PrebioticsAnimal FeedAnimalsCell WallDogsFecesFemaleGastrointestinal MicrobiomeHydrogen PeroxideImmunity, InnateInterleukin-6MaleMannansMonocytesOligosaccharidesSaccharomyces cerevisiaeHydrogen PeroxideInterleukin-6MannansOligosaccharidesPrebiotics

Identifiers

PMID31765439
PMCPMC6878821
OpenAlexW2990270001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.